BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3917454)

  • 1. Effects of growth hormone-releasing factor on growth hormone secretion in acromegaly.
    Gelato MC; Merriam GR; Vance ML; Goldman JA; Webb C; Evans WS; Rock J; Oldfield EH; Molitch ME; Rivier J
    J Clin Endocrinol Metab; 1985 Feb; 60(2):251-7. PubMed ID: 3917454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
    Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor.
    Borges JL; Blizzard RM; Evans WS; Furlanetto R; Rogol AD; Kaiser DL; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1984 Jul; 59(1):1-6. PubMed ID: 6427267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [GH and PRL after TRH and hpGRF(1-40) administration in 2 cases of acromegaly with hyperprolactinemia].
    Sampaolo G; Faloia E; Sarzani R; Bartolacci V; Schiavo P; Butini L; Morosini P
    Recenti Prog Med; 1987 Mar; 78(3):115-8. PubMed ID: 3110882
    [No Abstract]   [Full Text] [Related]  

  • 5. Human pancreatic growth hormone-releasing factor (hpGRF-44) in acromegaly before and after adenomectomy. Modifications induced by somatostatin (GHRIH) infusion.
    Arosio M; Ambrosi B; Guglielmino L; Faglia G
    J Endocrinol Invest; 1985 Oct; 8(5):449-53. PubMed ID: 2867112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
    J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptine.
    Chiodini PG; Liuzzi A; Dallabonzana D; Oppizzi G; Verde GG
    J Clin Endocrinol Metab; 1985 Jan; 60(1):48-52. PubMed ID: 3917270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of human pancreatic growth hormone-releasing factor-40 on serum growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and somatomedin-C concentrations in normal women throughout the menstrual cycle.
    Evans WS; Borges JL; Vance ML; Kaiser DL; Rogol AD; Furlanetto R; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1984 Nov; 59(5):1006-10. PubMed ID: 6434583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative stimulation of growth hormone secretion in anaesthetized chickens by human pancreatic growth hormone-releasing factor (hpGRF) and thyrotrophin-releasing hormone (TRH).
    Harvey S; Scanes CG
    Neuroendocrinology; 1984 Oct; 39(4):314-20. PubMed ID: 6436724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone responsiveness to human pancreatic growth hormone releasing factor in acromegaly: modulatory effects of basal hormone levels and of concomitant somatostatin administration.
    Pieters GF; Smals AE; Hermus AR; Smals AG; Benraad TJ; Kloppenborg PW
    Clin Endocrinol (Oxf); 1984 Dec; 21(6):701-7. PubMed ID: 6150772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human pancreatic growth hormone releasing factor (hpGRF): GRF- and GH-levels after bolus injection and infusion of hpGRF.
    von Werder K; Losa M; Stalla GK; Bock L; Müller OA
    Acta Neurochir (Wien); 1985; 75(1-4):81-7. PubMed ID: 2986424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
    Losa M; Schopohl J; König A; Müller OA; von Werder K
    J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly.
    Losa M; Oeckler R; Schopohl J; Müller OA; Alba-Lopez J; von Werder K
    J Neurosurg; 1989 Apr; 70(4):561-7. PubMed ID: 2647918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human pancreatic tumor growth hormone-releasing factor: dose-response relationships in normal man.
    Vance ML; Borges JL; Kaiser DL; Evans WS; Furlanetto R; Thominet JL; Frohman LA; Rogol AD; MacLeod RM; Bloom S
    J Clin Endocrinol Metab; 1984 May; 58(5):838-44. PubMed ID: 6423660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dexamethasone on growth hormone (GH) response to growth hormone releasing hormone in acromegaly.
    Nakagawa K; Akikawa K; Matsubara M; Kubo M
    J Clin Endocrinol Metab; 1985 Feb; 60(2):306-10. PubMed ID: 3917458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of synthetic human pancreatic growth hormone-releasing factor (hpGRF-44) on serum growth hormone response in normal and obese subjects].
    Shimizu T; Inoue K
    Nihon Naibunpi Gakkai Zasshi; 1986 Feb; 62(2):82-96. PubMed ID: 3084310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of human pancreatic tumour growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency.
    Borges JL; Blizzard RM; Gelato MC; Furlanetto R; Rogol AD; Evans WS; Vance ML; Kaiser DL; MacLeod RM; Merriam GR; Loriaux DL; Spiess J; Rivier J; Vale W; Thorner MO
    Lancet; 1983 Jul; 2(8342):119-24. PubMed ID: 6134978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation.
    Webb CB; Vance ML; Thorner MO; Perisutti G; Thominet J; Rivier J; Vale W; Frohman LA
    J Clin Invest; 1984 Jul; 74(1):96-103. PubMed ID: 6429198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure to respond to growth hormone releasing hormone (GHRH) in acromegaly due to a GHRH secreting pancreatic tumor: dynamics of multiple endocrine testing.
    Schulte HM; Benker G; Windeck R; Olbricht T; Reinwein D
    J Clin Endocrinol Metab; 1985 Sep; 61(3):585-7. PubMed ID: 3926812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma growth hormone (GH) response to GH-releasing factor in normal children with short stature and patients with pituitary dwarfism.
    Takano K; Hizuka N; Shizume K; Asakawa K; Miyakawa M; Hirose N; Shibasaki T; Ling NC
    J Clin Endocrinol Metab; 1984 Feb; 58(2):236-41. PubMed ID: 6420432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.